| | Studies examine cardiac safety of two new diabetes drugs Mon, 02 Sep, 2013 09:21 PM PDT Two studies published in the New England Journal of Medicine yesterday offered hope for doctors, patients and pharmaceutical firms concerned about the potential negative cardiovascular effects of new drugs designed to combat Type 2 diabetes. A new class of drugs known as DPP-4 inhibitors did not appear... Continue reading | |
No comments:
Post a Comment